Patent · US Active

Allergen desensitization method

US12403193B2 · kind B2 · utility

0Cited by
60References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 14, 2024
Grant dateSep 2, 2025
Priority date
Expiry dateFeb 14, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/545
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to a method for desensitization of allergic patients. More specifically it relates to an epicutaneous desensitization method, applicable to any type of allergens and of patients. The method of the invention is essentially non-invasive and does not require the use of adjuvants. Further, it may be easily applied and monitored by the actual patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.